Antigens are used for the production of antibodies. These can be toxins or other substances, which induce an immune response in the body. Antigens are also known as antibodies. These are microbes such as bacteria, parasites, fungi, and other antigen such as pollen. Antigen kits are used to detect antigen of various diseases such as malaria, dengue, and influenza. Antigen test kits are primarily used in rapid medical diagnostics, in vitro diagnostic devices, and molecular diagnostics. Antibodies can be measured and detected from blood sample and saliva. Some antibody tests are useful to detect past infections or to diagnose a persisting infection.
The global antigen kit market is expected to grow in the near future owing to increasing demand for antigen kit in various application segments such as rapid medical diagnostics, in vitro diagnostic device, and molecular diagnostics. Increasing prevalence of liver diseases, autoimmune diseases, and sexually transmitted diseases are expected to propel the growth of the antigen market during the forecast period. According to the American Autoimmune Related Diseases Association (AARDA) currently 50 million people in the U.S. are living with autoimmune diseases. Autoantibody/autoantigen tests are used to diagnose autoimmune disorders. These are also used to evaluate the severity of the condition and monitor effectiveness of treatment and relapses of the disorders. Autoantibody tests are performed when a patient is suffering from chronic, progressive arthritic symptoms, fatigue, fever, and muscle weakness. According to the World Health Organization, around 203 million cases of malaria were reported worldwide in 2012. The disease accounted for nearly 627,000 deaths globally in the same year. Cross-reaction and false negative results are likely to hamper the growth of the market during the forecast period.
The global antigen kit market has been segmented based on technique, application, end-user, and region. In terms of technique, the market has been categorized into precipitation reaction, agglutination reaction, complement fixation, immunofluorescent assay, enzyme-linked immunosorbent assay (ELISA), and radioimmunoassay. Based on application, the market has been divided into tropical diseases, liver diseases, autoimmune diseases, and sexually transmitted diseases. End-users in this market include hospitals, diagnostics centers, clinics, and others.
Geographically, the global antigen kit market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was the largest market for antigen kits due to increasing prevalence of autoimmune diseases and rising incidence of sexually transmitted diseases. According to the Centers for Disease Control and Prevention (CDC), nearly 20 million new sexually transmitted infections occur in the U.S. each year, half among young people aged 15 years to 24 years, and account for nearly US$ 16 Bn in health care costs. Europe was the second largest market for antigen kits owing to increasing incidence of liver diseases. According to the European Association for the Study of the Liver, in 2013, liver cirrhosis accounted for 170,000 deaths in Europe and nearly 63,500 new cases of liver cancer were diagnosed in Europe in 2012. Acceptance and demand for high-end medical infrastructure are the major factors driving the market in Asia Pacific. China, Japan, and India are the fast growing markets in the region and are projected to fuel market growth. Countries in Latin America such as Brazil and Mexico have significant potential owing to evolving medical structure and high disposable income.
Major players operating in the antigen kit market include Thermo Fisher Scientific, SD BIOSENSOR, Inc., SinoBiological, Inc., Cell Biolabs, Inc., Affinity Biologicals Inc., R-Biopharm AG, Epitope Diagnostics, Inc., and Oxford BioMedica.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.